Fierce Pharma

JANUARY 8, 2024

Biopharma companies looking to maximize the visibility of their M&A activity often reveal deals during the J.P. In it’s annual Firepower report, EY says the biopharma industry enters 2024 with the capability and motivation to increase M&A activity. Morgan Healthcare Conference. |

Prospecting 231

Prospecting Biopharma Pharma Healthcare 231

Fierce Pharma

JANUARY 23, 2023

Call for nominations: The most influential people in biopharma in 2023 esagonowsky Mon, 01/23/2023 - 14:32

Biopharma 130

Biopharma 130

Fierce Pharma

MAY 16, 2023

FTC seeks to block Amgen's $28B Horizon buy in 'broadly negative' move for biopharma M&A: report aliu Tue, 05/16/2023 - 09:41

Biopharma 280

Biopharma 280

Fierce Pharma

MAY 22, 2023

Pfizer, Moderna among many biopharma giants to post Q1 sales declines, as Novo Nordisk led growth charge kdunleavy Mon, 05/22/2023 - 13:04

Biopharma 262

Biopharma Sales 262

Fierce Pharma

MARCH 21, 2023

Biopharma industry lobbies for tax breaks related to US-based manufacturing kdunleavy Tue, 03/21/2023 - 11:14

Biopharma 248

Biopharma Manufacturing 248

Fierce Pharma

MAY 9, 2023

Let's make a deal: Conditions are right for biopharma M&A to break out, analysts say kdunleavy Tue, 05/09/2023 - 10:18

Biopharma 225

Biopharma 225

Fierce Pharma

DECEMBER 22, 2023

Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.

Biopharma 341

Biopharma 341

Fierce Pharma

NOVEMBER 22, 2022

2023 preview: Despite Biden's drug pricing win, the biopharma industry is not 'anywhere near done with this conversation'. esagonowsky. Tue, 11/22/2022 - 14:22.

Biopharma 130

Biopharma 130

Fierce Pharma

MAY 25, 2023

The Top Line': The 20 most influential people in biopharma, plus this week's headlines tcarey Thu, 05/25/2023 - 14:21

Biopharma 195

Biopharma 195

Fierce Pharma

APRIL 19, 2023

Alnylam, Intra-Cellular among analyst's top picks for M&A as biopharma dealmaking heats up aliu Wed, 04/19/2023 - 14:39

Biopharma 201

Biopharma 201

Fierce Pharma

FEBRUARY 21, 2024

In a year that started with more than two-thirds of biopharma companies posting | While Novo Nordisk and Eli Lilly continued to be the biopharma industry growth leaders in the fourth quarter of 2023, many other drugmakers also delivered big gains, including Daiichi Sankyo, Amgen, Teva, GSK and Novartis.

Leads 263

Leads Biopharma Sales 263

Fierce Pharma

MAY 9, 2023

We want your stories: Biopharma's collective memory of COVID—in photographs aliu Tue, 05/09/2023 - 14:56

Biopharma 148

Biopharma 148

Fierce Pharma

JANUARY 3, 2024

Booming demand for blood sugar-modulating diabetes and obesity drugs became the top trend in the biopharma industry in 2023, with two companies—Novo Nordisk and Eli Lilly—overwhelming the market wi | Booming demand for blood sugar-modulating diabetes and obesity drugs became the top trend in the biopharma industry in 2023, with two companies—Novo Nordisk (..)

Sales 273

Sales Biopharma Leads Marketing 273

Pharma Pathway

FEBRUARY 28, 2023

Hetero Biopharma-Walk-In Interview for M.Sc/ B.Sc/ Diploma in Production On 4th Mar’ 2023 Job Description Greetings from Hetero Biopharma !!! Walk-In Interview for M.Sc/ B.Sc/ Diploma in Production @ Hetero Biopharma Department: Production Designation: Executive to Sr. 7-2-A2, Sanath Nagar, Opp.

Biopharma 81

Biopharma Pharma 81

Pharma Pathway

FEBRUARY 23, 2023

Position: 26 Date: 26th Feb’ 2023 Time: 10:00 AM to 03:00 PM Venue: Celebrity Biopharma Limited, Vill -Panga Hilltop, Estate Via Jharmajri Distt. Celebrity Biopharma Limited (Aishwarya Group)-Walk-In Interviews for QA/ QC/ Production On 26th Feb’ 2023

Biopharma 80

Biopharma Pharma 80

PharmExec

OCTOBER 13, 2023

Exploring the pharma and biotech financing, M&A, and stock market pictures through the first half of 2023—and implications for the future, as market challenges continue to weigh heavily in senior management decision-making.

Marketing 104

Marketing Biopharma Pharma Management 104

Pharma Pathway

FEBRUARY 14, 2023

Manvi Biopharma Pvt. Ltd- Walk-In Interviews for Production/ Quality Control On 15th Feb’ 2023 Job Description Walk-In Interviews for Production/ Quality Control On 15th Feb’ 2023 @ Manvi Biopharma Pvt. Manvi Biopharma Pvt. Ltd Department: Production/ Quality Control Posts: Chemist/ Sr.

Biopharma 52

Biopharma Pharma 52

Zymewire

JANUARY 24, 2024

Unlocking the financial pulse of the biotech and pharma industry. A must-read for sales professionals navigating the terrain of biotech and pharma funding

Biopharma 52

Biopharma Pharma Sales 52

Pharma Pathway

FEBRUARY 3, 2023

Hetero Biopharma-Walk-In Interview for M.Sc/ B.Tech Biochemistry/ Biotechnology in Production On 4th Feb’ 2023 Job Description Greetings from Hetero Biopharma !!! Walk-In Interview for M.Sc/ B.Tech Biochemistry/ Biotechnology in Production @ Hetero Biopharma Department: Production Designation: Executive to Sr.

Biopharma 52

Biopharma Pharma 52

European Pharmaceutical Review

DECEMBER 20, 2023

In Q1 2023, the European Commission (EC) announced proposed changes to EU pharmaceutical legislation. 1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. analysis (Source: L.E.K) What are the latest amendments?

Biopharma 80

Biopharma Pharmaceutical Medicine Manufacturing 80

European Pharmaceutical Review

FEBRUARY 21, 2023

Included in this issue of European Pharmaceutical Review : FOREWORD Accelerating drug development David Elder, David P Elder Consultancy RAMAN SPECTROSCOPY Shining a light on Raman for microbiological analysis Tim Sandle, Bio Products Laboratory LIMS Overcoming barriers to capturing data in a laboratory Samantha Kanza, University of Southampton ENVIRONMENTAL (..)

Pharmaceutical 98

Pharmaceutical Biopharma Consulting Pharma 98

MedCity News

MARCH 24, 2024

based pharma companies. The survey was conducted in late 2023 and results were reported this month. Lack of automation is the top challenge facing commercialization teams, according to a survey of executives at U.S.-based

Pharma 78

Pharma Biopharma 78

Clarivate

JULY 24, 2023

Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting their intellectual property. The post Pharmas and medtechs flex brand protection among Top 100 New Brands for 2023 appeared first on Clarivate.

Pharma 52

Pharma Biopharma Prospecting Training 52

pharmaphorum

DECEMBER 15, 2022

The month of November saw a number of notable hires and personnel moves in biotech and pharma. New CEO in at Angelini Pharma. Jacopo Andreose will take over as CEO of Angelini Pharma, a subsidiary of Angelini Industries, in February 2023, the Italian company announced last month. Other biopharma hires.

Biopharma 52

Biopharma Pharma Sales Management 52

Clarivate

OCTOBER 31, 2023

These years witnessed significant troughs in pharma financing, a drop in the capital markets, and an IPO window that remained firmly shut. Big pharma is still keen to access good technology, science, and assets, in many cases to plug a patent-expiry-shaped hole in their coffers. In short, the biotech bubble had burst. Pfizer’s $11.6

Pharma 52

Pharma Biopharma Marketing Healthcare 52

Clarivate

JANUARY 10, 2023

However, because they are highly targeted, they address smaller potential patient cohorts than the mass-market treatments of yore, forcing pharmas to thread the needle on pricing in order to recoup the costs of development and fund the next cycle of innovation. The post The Drugs to Watch in 2023 appeared first on Clarivate.

Biopharma 59

Biopharma Medicine Marketing Patients 59

PharmaTech

JANUARY 9, 2024

Bradley Grobler, Vice President of Sales, Pharma & Biopharma Europe, describes how Actylis meets global demands for (bio)pharmaceutical development and manufacturing programs during CPhI 2023.

Manufacturing 52

Manufacturing Biopharma Pharma Sales 52

PharmaTech

JULY 17, 2023

Unlock the full potential of your pharma/biopharma laboratory with our comprehensive guide on mastering liquid handling techniques for any liquid type.

Biopharma 52

Biopharma Pharma 52

MedCity News

DECEMBER 15, 2022

2023 is shaping up to be a crucial year for everyone involved – and affected – by the pharmaceutical industry. It’s likely to be a year of experimentation for payers – and defensiveness for drug makers.

Insurance 91

Insurance Pharma Pharmaceutical Biopharma 91

pharmaphorum

DECEMBER 23, 2022

And in 2023, these investments will hopefully pay off. With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance. Marketing data will surpass health data as a leading signal for pharma advertisers.

Marketing 92

Marketing Sales Medical Patients 92

European Pharmaceutical Review

JANUARY 12, 2023

Out of 19 companies honoured with the 2022 Terra Carta Seal, the three pharma companies awarded were: GlaxoSmithKline PLC. Being awarded the 2022 Terra Carta Seal is confirmation of GSK demonstrating its commitment to climate responsibility for its supply chain in force from 2023. Samsung Biologics.

Pharma 90

Pharma Biopharma Manufacturing Government 90

Clarivate

MAY 31, 2023

A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. Pharma is placing bigger bets on a smaller number of therapeutics and technology platforms.

Pharma 52

Pharma Biopharma Medicine Competition 52

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy.

Consulting 122

Consulting Biopharma Manufacturing Pharmaceutical 122

PM360

DECEMBER 14, 2023

Moderna Joins CEPI Pandemic Preparedness Mission After making its debut in the pharma market during the COVID-19 pandemic, Moderna is preparing for the next pandemic. The pharma company has joined the Coalition for Epidemic Preparedness Innovations (CEPI) in a partnership that aims to shorten vaccine development timelines down to 100 days.

Physicians 52

Physicians Pharma Medical Patients 52

PM360

OCTOBER 3, 2023

PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Director, Obesity Market Access Strategy, Novo Nordisk Medical Device/Diagnostics: Brett Sarnoff, Vice President of Marketing Medical Device & Pharma Systems, North America, B. Braun Medical, Inc.

Education 122

Education Marketing Media Management 122

MedCity News

DECEMBER 29, 2022

Many pharma and medical device companies will look inward, with the goal of standardizing and modernizing even highly regulated activities. Here’s a closer look at some important industry trends for 2023.

Pharma 78

Pharma Medical Biopharma 78

pharmaphorum

JANUARY 10, 2023

As two in five pharma leaders say that moving to a consumer-first mindset is a priority for the next two years, digital customer experience agency Graphite Digital is to publish a special edition of its Contradiction Conundrum whitepaper report, released in partnership with Reuters Events Pharma last year.

Pharma 52

Pharma Specialization Sales Biopharma 52